Exhibit 10.6
MAIA BIOTECHNOLOGY, INC.
[Consulting] [Director] Stock Option Award Agreement
Name of Grantee: |
|
Date of Grant: |
|
Vesting Commencement Date: |
|
Number of Option Shares: |
|
Option Price: | $ |
Type of Option: | Non-qualified Stock Option |
Applicable Plan: | The 2021 Equity Incentive Plan (the “Plan”) |
Vesting: |
|
Purpose: |
|
|
|
DOCPROPERTY "DocID" \* MERGEFORMAT 22527540.2 |
|
|
MAIA BIOTECHNOLOGY, INC.
2021 EQUITY INCENTIVE PLAN
NON-QUALIFIED STOCK OPTION AGREEMENT
THIS AGREEMENT made as of ___________ __, 2021 [insert date on which Committee grants the Option] (the “Grant Date”), by and between Maia Biotechnology, Inc. (the “Company”), and ____________________ (the “Optionee”).
WITNESSETH:
WHEREAS, the Company has adopted and maintains the Maia Biotechnology, Inc. 2021 Equity Incentive Plan, effective August 1, 2022 (the “Plan”), and
WHEREAS, the Committee has authorized the grant to the Optionee of an Option under the Plan, on the terms and conditions set forth in the Plan and as hereinafter provided,
NOW, THEREFORE, in consideration of the premises contained herein, the Company and the Optionee hereby agree as follows:
DOCPROPERTY "DocID" \* MERGEFORMAT 22527540.2 | 2 |
|
(c) The Option price may be paid, in whole or in part, by (i) an immediate market sale or margin loan as to all or a part of the Shares which the Optionee shall be entitled to receive upon exercise of the Option, pursuant to an extension of credit by the Company to the Optionee of the Option price (or portion thereof to be so paid), (ii) the delivery of the Shares from the Company directly to a brokerage firm, and (iii) the delivery of the Option price from sale or margin loan proceeds from the brokerage firm directly to the Company.
(d) The Option price may be paid, in whole or in part, by reducing the number of Shares to be issued upon exercise of the Option by the number of Shares having an aggregate Fair Market Value equal to the Option price (or portion thereof to be so paid) as of the date of the Option’s exercise.
DOCPROPERTY "DocID" \* MERGEFORMAT 22527540.2 | 3 |
|
DOCPROPERTY "DocID" \* MERGEFORMAT 22527540.2 | 4 |
|
| MAIA BIOTECHNOLOGY, INC. | |
| By:_______________________________ Title:_____________________________
|
|
| OPTIONEE By:_______________________________ Title:_____________________________
|
|
DOCPROPERTY "DocID" \* MERGEFORMAT 22527540.2 | 5 |
|
SAMPLE
NOTICE OF EXERCISE
Maia Biotechnology, Inc. | Date of Exercise: | |
|
|
|
Ladies and Gentlemen:
This constitutes notice under my stock Option that I elect to purchase the number of Shares for the price set forth below.
Type of Option: | Non-Qualified |
|
|
|
|
Grant Date: |
|
|
|
|
|
Number of Shares as |
|
|
|
|
|
Certificates to be |
|
|
|
|
|
Total exercise price: | $ |
|
|
|
|
Cash payment delivered | $ |
|
By this exercise, I agree (i) to execute or provide such additional documents as Maia Biotechnology, Inc. (the “Company”) may reasonably require pursuant to the terms of this Notice of Exercise and the Company’s 2021 Equity Incentive Plan (the “Plan”), and (ii) to provide for the payment by me to the Company (in the manner designated by the Company) of the Company’s withholding obligation, if any, relating to the exercise of this Option.
Very truly yours,
___________________________________________
Optionee
DOCPROPERTY "DocID" \* MERGEFORMAT 22527540.2 | 6 |
|